Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
High-resolution Nanopore methylome-maps reveal random hyper-methylation at CpG-poor regions as driver of chemoresistance in leukemias.[RNA-Seq]
PubMed Full text in PMC Similar studies
Illumina NovaSeq 6000 (Homo sapiens)
RNA-Seq of AML patient (UD5), relapse phase, replicate 3
SRA Run Selector
RNA-Seq of AML patient (UD10), onset phase, replicate 3
RNA-Seq of AML patient (UD10), relapse phase, replicate 3
RNA-Seq of AML patient (AML2), onset phase, replicate 3
RNA-Seq of AML patient (AML2), relapse phase, replicate 3
RNA-Seq of AML patient (UD5), onset phase, replicate 2
RNA-Seq of AML patient (UD5), relapse phase, replicate 2
RNA-Seq of AML patient (UD10), onset phase, replicate 2
RNA-Seq of AML patient (UD10), relapse phase, replicate 2
RNA-Seq of AML patient (AML2), onset phase, replicate 2
RNA-Seq of AML patient (AML2), relapse phase, replicate 2
RNA-Seq of AML patient (UD5), onset phase, replicate 1
RNA-Seq of AML patient (UD5), relapse phase, replicate 1
RNA-Seq of AML patient (UD10), onset phase, replicate 1
RNA-Seq of AML patient (UD10), relapse phase, replicate 1
RNA-Seq of AML patient (AML2), onset phase, replicate 1
RNA-Seq of AML patient (AML2), relapse phase, replicate 1
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on